header logo image


Page 5«..4567..1020..»

Archive for the ‘Cell Therapy’ Category

Topeka Zoo’s bear gets CT scan, stem cell therapy

Monday, February 2nd, 2015

Peek, a 20-year-old American Black Bear living at the Topeka Zoo, is undergoing treatment, including a CT scan, for back condition, zoo director Brendan Wiley said Monday.

Peek came out of her den two weeks ago and her keeper noticed the bears hind legs were wobbly. Peek was given pain medication. However, the condition quickly worsened, Wiley said in a news release.

Peek within the next seven days continued to lose control of her rear legs.

One of the unique things about this scenario is that Peek hasnt acted like anything is hurting her, said Shanna Simpson, animal care supervisor. It is like the front half of her body can no longer communicate with the back half. Peeks illness required the use of a CT scan, which used equipment the zoo doesnt have, Wiley said.

Zoo veterinarian Shirley Llizo brought in Larry Snyder and Travis Gratton, of University Bird and Small Animal Hospital, to help harvest fat cells from Peek. This would allow the fat cells to be converted to stem cells to be injected.

Peek was tranquilized Jan. 22 and transported to the zoos hospital so the fat cells could be harvested. After the harvest, Peek was transported to St. Francis Health Center, where she was met by Brent Wilkins, director of imaging services, and his staff.

After confirming Peek would fit in the 72-centimeter CT scanner, Wilkins was able to do the scan, and radiologist James Owen found an area of Peeks spine was experiencing spinal stenosis. This is a narrowing of the spinal column that causes pressure on the spinal cord, according to zoo officials.

Our first priority is human patient safety and access, Wilkins said. We work with the Topeka Zoo to accommodate animals that need CT scans in off hours when one of our CT scanners is available. We made sure the bear was separated from any other patients and performed a high-level decontamination and cleaning of the area, called a terminal cleaning, after the bears visit. Were very happy to help our friends at the zoo in keeping the animals healthy.

After the CT scan, Peek went back to the zoo, where she received the stem cell therapy. Stem cell therapy treatment in bears is new technology, Wiley said. It is believed that Peek is the first bear to undergo this type of therapy, Wiley said in a news release. In the event Peek should need a second round of stem cell therapy, a cryogenic lab in Kentucky is maintaining the rest of the sample that was produced from Peeks fat cells.

Last week, Peek showed her first sign of improvement. However, she is still considered to have a poor prognosis, Llizo said.

Continued here:
Topeka Zoo's bear gets CT scan, stem cell therapy

Read More...

Tampa stem cell clinic is long on promises, not evidence

Sunday, February 1st, 2015

TAMPA Dr. Burton Feinerman has spent more than a decade using stem cell therapies that are banned in the United States, sending desperate families to Peru seeking treatments for their babies' terminal conditions like Tay-Sachs disease.

The therapies are costly and unproven, and no insurer will cover them. But there is no law against a U.S. doctor recommending them, as long as they aren't performed here.

Now the 85-year-old pediatrician is focusing on a stem cell therapy he can perform in Tampa, for seniors with such incurable lung conditions as chronic obstructive pulmonary disease, or COPD.

Feinerman, medical director of the Tampa-based Lung Institute, says lung patients tend to get the most benefit from stem cell therapies. And he can treat them in the United States because he is re-infusing patients with their own stem cells, a legal process under certain circumstances.

But it's not approved as a lung disease therapy in this country. Neither the American Lung Association nor the International Society for Stem Cell Research have endorsed it. Medicare won't cover it.

So Feinerman's patients must pay cash between $7,500 and $12,000 for a three-day treatment, plus $4,500 for additional "boosters'' of cells extracted from their blood or abdominal fat.

The Lung Institute has produced a slick website and an advertising campaign, and it puts on seminars at which prospects can hear the testimonials of satisfied patients.

But there are no clinical data showing stem cell therapies benefit patients with lung disease, said Dr. Daniel Weiss, a professor at the University of Vermont College of Medicine and a leading lung disease researcher. Further, studies of mice suggest that if the therapies work, it likely would help only acute lung conditions like respiratory distress syndrome, not chronic conditions like COPD.

"I do not recommend any type of cell therapy (for lung disease) at this point," Weiss said.

Feinerman insists the doubters are wrong. "Just go to Google," he told a Times reporter who asked him for clinical research to back his claims. Lung Institute employees later provided citations for three journal articles, but none showed the treatments worked. In fact, Weiss wrote two of the articles.

Here is the original post:
Tampa stem cell clinic is long on promises, not evidence

Read More...

Stem Cell Therapy + PRP Therapy Helps Pelvic Pain Patient – Video

Saturday, January 31st, 2015


Stem Cell Therapy + PRP Therapy Helps Pelvic Pain Patient
Stem Cell ARTS Actual Patient Testimonial--Julie Mariano "I had some abdominal surgery a few years ago and woke up with extreme back pain. It was a complete mystery how it happened and it still...

By: StemCell ARTS

Read more from the original source:
Stem Cell Therapy + PRP Therapy Helps Pelvic Pain Patient - Video

Read More...

Knee problems and stem cell therapy – Video

Saturday, January 31st, 2015


Knee problems and stem cell therapy
Dr. Scott Greenberg discusses stem cell procedures for the knee and his experience with athletes, torn meniscus issues, and arthritis.

By: scott greenberg

See the rest here:
Knee problems and stem cell therapy - Video

Read More...

Denver Regenerative Medicine – What is regenerative medicine? – Video

Friday, January 30th, 2015


Denver Regenerative Medicine - What is regenerative medicine?
Dr. Joel Cherdack of Denver Regenerative Medicine explains what regenerative medicine is. He and the hosts discuss the benefits of both PRP (platelet rich plasma) and Stem Cell Therapy.

By: Denver Regenerative Medicine

Read this article:
Denver Regenerative Medicine - What is regenerative medicine? - Video

Read More...

13 ABC: Advancements in stem cell therapy – 1/27/15 – Video

Friday, January 30th, 2015


13 ABC: Advancements in stem cell therapy - 1/27/15
ProMedica Physician Roger Kruse, MD, discusses use of stem cell therapy in orthopedic care.

By: ProMedica In The News

See original here:
13 ABC: Advancements in stem cell therapy - 1/27/15 - Video

Read More...

Stem Cell Therapy Treatment for Limb Girdle Muscular Dystrophy by Dr.PV Mahajan – Video

Thursday, January 29th, 2015


Stem Cell Therapy Treatment for Limb Girdle Muscular Dystrophy by Dr.PV Mahajan
Patient testimonial of Limb Girdle Muscular Dystrophy treated by StemRx Bioscience Solutions Pvt. Ltd.

By: StemRx BioScience

Read the original here:
Stem Cell Therapy Treatment for Limb Girdle Muscular Dystrophy by Dr.PV Mahajan - Video

Read More...

Stem Cell Therapy + PRP Helps Shoulder Injury and Whiplash Patient – Denise Lawson – Video

Thursday, January 29th, 2015


Stem Cell Therapy + PRP Helps Shoulder Injury and Whiplash Patient - Denise Lawson
Denise Lawson experienced two motor vehicle accidents in 2001 that left her with neck pain, headaches, and sporadic episodes of weakness on the left side of her body. Over time, Denise developed...

By: StemCell ARTS

Read more:
Stem Cell Therapy + PRP Helps Shoulder Injury and Whiplash Patient - Denise Lawson - Video

Read More...

Parkinson’s Disease: Mr Garnet’s experience 6 months after stem cell therapy by Harry Adelson, N.D. – Video

Saturday, January 24th, 2015


Parkinson #39;s Disease: Mr Garnet #39;s experience 6 months after stem cell therapy by Harry Adelson, N.D.
At Docere Clinics, our clinical focus is on the treatment of musculoskeletal pain disorders. On rare occasions, we have patients, usually relatives of satisf...

By: Harry Adelson, N.D.

Read more:
Parkinson's Disease: Mr Garnet's experience 6 months after stem cell therapy by Harry Adelson, N.D. - Video

Read More...

Thursday 01/22: Celebrity Transformations; Stem Cell Therapy Debate; Samantha Harris Health Crisis – Video

Friday, January 23rd, 2015


Thursday 01/22: Celebrity Transformations; Stem Cell Therapy Debate; Samantha Harris Health Crisis
http://www.thedoctorstv.com Subscribe to The Doctors: http://bit.ly/SubscribeTheDrs LIKE us on Facebook: http://bit.ly/FacebookTheDoctors Follow us on Twitter: http://bit.ly/TheDrsTwitter Follow...

By: The Doctors

Originally posted here:
Thursday 01/22: Celebrity Transformations; Stem Cell Therapy Debate; Samantha Harris Health Crisis - Video

Read More...

The New Stem Cell Therapy 2015 – Video

Friday, January 23rd, 2015


The New Stem Cell Therapy 2015
Regener8 Hair.

By: Regener8 Hair

Read the original post:
The New Stem Cell Therapy 2015 - Video

Read More...

Stem Cell Therapy | Recent Strides Quell Stem Cell Debate – Video

Tuesday, January 20th, 2015


Stem Cell Therapy | Recent Strides Quell Stem Cell Debate
Ethical concerns for stem cells for arthritis could be mute...maybe. Reports show that adult stem cells (Autologous) have been shown in recent studies to have significant effects on osteoarthritis...

By: Nathan Wei

Read the original here:
Stem Cell Therapy | Recent Strides Quell Stem Cell Debate - Video

Read More...

MS patients given stem cells improve

Tuesday, January 20th, 2015

Stem cell therapy may have helped patients with a form of multiple sclerosis, according to a preliminary study.

Patients with relapsing-remitting multiple sclerosis showed signs of improvement after being treated with their own, or autologous "nonmyeloablative hematopoietic stem cells," a class of blood-forming stem cells, the study found. It was published Tuesday in the Journal of the American Medical Association.

Half, or 41 patients, tested two years after treatment experienced significant improvement on the Expanded Disability Status Scale, a measure of disability. And of patients tested at 4 years, 23, or 64 percent, showed significant improvement. Four-year relapse-free survival was 80 percent and progression-free survival was 87 percent.

"To our knowledge, this is the first report of significant and sustained improvement in the EDSS score following any treatment for MS," stated the study. It was led by Dr. Richard K. Burt of Northwestern University in Chicago.

However, only limited conclusions can be drawn from the uncontrolled study, according to scientists who examined the results. While the therapy was associated with improvement, the stem cell transplant may not have been key. A conditioning regimen that partially depleted the stem cells before transplantation may have been responsible, said Dr. Stephen L. Hauser in a JAMA article accompanying the study.

"According to Carl Sagan, 'extraordinary claims require extraordinary evidence,' a standard that is not always met in this report, and not claimed by the authors. Even though the authors appropriately acknowledge many of the limitations associated with their case series, their statement that 'to our knowledge, this is the first report of significant and sustained improvement in the EDSS score following any treatment for MS' could be challenged," Hauser wrote.

Jeanne Loring, a stem cell researcher who studies multiple sclerosis and other neurodegenerative diseases, agreed that the results are far from conclusive.

"Multiple sclerosis is an autoimmune disease, meaning that the patients' own immune cells attack their own nervous systems," Loring said by email after examining the study. "The authors of the JAMA article treated MS patients with their own blood stem cells in the hope that these cells would replace some of the self-destructive immune cells."

However, the uneven course of MS makes it hard to draw conclusions, wrote Loring, who heads the Center for Regenerative Medicine at The Scripps Research Institute in La Jolla.

"Most patients with MS have attacks, followed by recovery, followed by another attack. In a few of these patients, the blood stem cell treatment seemed to extend their time between attacks. It's important to understand that other treatments, including drugs, have shown similar modest improvements, so it's too soon to celebrate a stem cell therapy."

See the article here:
MS patients given stem cells improve

Read More...

Dr Sherif Stem cell therapy on OA – Video

Sunday, January 18th, 2015


Dr Sherif Stem cell therapy on OA
lecture powerpoint.

By: Medical Center

Go here to see the original:
Dr Sherif Stem cell therapy on OA - Video

Read More...

Winnipeg company offering stem cell therapy is fraudulent, MS sufferer alleges

Sunday, January 18th, 2015

A Winnipeg-based company that has touted its ability to improve the lives of Multiple Sclerosis patients through stem cell therapy is now under the microscope after allegations of fraud from a client.

The CEO of Regenetek Research Inc. has been collecting thousands of dollars from Canadian patients looking for help. Some of the patients are now questioning the research and credentials of the man they know as Dr. Doug.

One of them is Lee Chuckry, 47. He has been living with MS for nearly two decades.

MS just keeps progressing, thats what it does. Hopefully I could stop it. That was my ultimate goal, Chuckry said in an interview with CTV News.

His efforts led him to Regenetek, and its CEO: Doug Broeska.

In testimonials, MS patients attributed miraculous medical improvement to experimental stem cell therapy. For $35,000, Regenetek patients were flown to India for the procedure.

Chuckry was one of the participants. But when he returned home, he says his symptoms worsened.

When he started digging deeper, he said, he found the doctor hed put his faith in wasnt what he claimed to be.

Im going to call Doug a con artist, Chuckry said. You are preying on people who are desperate. They are looking for hope of any sort.

Chuckry and at least one other patient have gone to the RCMP. They allege Broeska, who claims to hold a PhD and a Bachelor of Science, is a fraud who is operating as a medical researcher without proper credentials.

Original post:
Winnipeg company offering stem cell therapy is fraudulent, MS sufferer alleges

Read More...

Stem Cell Therapy: A cure for Diabetes | PlacidWay – Video

Wednesday, January 14th, 2015


Stem Cell Therapy: A cure for Diabetes | PlacidWay
http://tiny.cc/DiabetesCure2015 Diabetes treatment can consist of numerous elements, consisting of standard medications, alternative medication, and natural treatments. Alternative therapies...

By: Robert Esser

Continued here:
Stem Cell Therapy: A cure for Diabetes | PlacidWay - Video

Read More...

Is stem cell therapy less effective in older patients with chronic diseases?

Monday, January 12th, 2015

IMAGE:BioResearch Open Access is a bimonthly peer-reviewed open access journal led by Editor-in-Chief Robert Lanza, MD, Chief Scientific Officer, Advanced Cell Technology, Inc. and Editor Jane Taylor, PhD. The Journal... view more

Credit: Mary Ann Liebert, Inc., publishers

New Rochelle, NY, January 12, 2014--A promising new therapeutic approach to treat a variety of diseases involves taking a patient's own cells, turning them into stem cells, and then deriving targeted cell types such as muscle or nerve cells to return to the patient to repair damaged tissues and organs. But the clinical effectiveness of these stem cells has only been modest, which may be due to the advanced age of the patients or the effects of chronic diseases such as diabetes and cardiovascular disease, according to a probing Review article published in BioResearch Open Access, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers . The article is available on the BioResearch Open Access website.

Anastasia Yu. Efimenko, TN Kochegura, ZA Akopyan, and YV Parfyonova, Moscow State University (Russia), analyze how aging and chronic diseases might affect the regenerative potential of autologous stem cells and explain the differences between the promising results reported in preclinical studies using stem cells derived from healthy young donors and the more modest success of clinical studies in aged patients. The authors propose strategies to test for and enhance to regenerative properties and therapeutic potential of stem cells in the article "Autologous Stem Cell Therapy: How Aging and Chronic Diseases Affect Stem and Progenitor Cells".

"This review discusses a very important issue in regenerative medicine, how aging and chronic pathologies such as cardiovascular diseases and metabolic disorders affect adult stem/progenitor cells," says BioResearch Open Access Editor Jane Taylor, PhD, MRC Centre for Regenerative Medicine, University of Edinburgh, Scotland. "Future therapies are discussed by the authors in terms of overcoming or correcting the limitations of these cells in order to enhance their therapeutic potential."

###

About the Journal

BioResearch Open Access is a bimonthly peer-reviewed open access journal led by Editor-in-Chief Robert Lanza, MD, Chief Scientific Officer, Advanced Cell Technology, Inc. and Editor Jane Taylor, PhD. The Journal provides a new rapid-publication forum for a broad range of scientific topics including molecular and cellular biology, tissue engineering and biomaterials, bioengineering, regenerative medicine, stem cells, gene therapy, systems biology, genetics, biochemistry, virology, microbiology, and neuroscience. All articles are published within 4 weeks of acceptance and are fully open access and posted on PubMed Central. All journal content is available on the BioResearch Open Access website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many areas of science and biomedical research, including DNA and Cell Biology, Tissue Engineering, Stem Cells and Development, Human Gene Therapy, HGT Methods, and HGT Clinical Development, and AIDS Research and Human Retroviruses. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

More here:
Is stem cell therapy less effective in older patients with chronic diseases?

Read More...

Gamida Cell’s NiCord gets FDA and EMA orphan drug status

Wednesday, January 7th, 2015

Published 07 January 2015

Gamida Cell, a leader in cell therapy technologies and products for transplantation and adaptive immune therapy, announced that orphan drug designation has been granted by The US Department of Health and Human Services, The FDA Office of Orphan Products Development (OOPD) for the investigational medicinal product NiCord for the treatment of acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Hodgkin lymphoma and myelodysplastic syndrome (MDS).

The FDA orphan drug designation coincides with the positive opinion of the European Medicines Agency's (EMA's) Committee for Orphan Medicinal Products (COMP) regarding NiCord as a treatment for AML. Gamida Cell intends to file for NiCord orphan drug status with the EMA for other indications as well.

"Receipt of orphan drug status for NiCord in the US and Europe advances Gamida Cell's commercialization plans a major step further, as both afford significant advantages. We very much appreciate the positive feedback and support of the FDA and EMA and look forward to continuing what has been a very positive dialogue with these important agencies," said Gamida Cell president and CEO Dr. Yael Margolin.

The FDA and EMA grant an orphan drug designation to promote the development of products that demonstrate promise for the treatment of rare diseases or conditions. Orphan drug designation provides for various regulatory and economic benefits, including seven years of market exclusivity in the U.S. and 10 years in the EU.

NiCord is derived from a single cord blood unit which has been expanded in culture and enriched with stem cells using Gamida Cell's proprietary NAM technology.

It is currently being tested in a Phase I/II study as an investigational therapeutic treatment for hematological malignancies such as leukemia and lymphoma. In this study, NiCord is being used as the sole stem cell source.

Here is the original post:
Gamida Cell's NiCord gets FDA and EMA orphan drug status

Read More...

Restore and Regenerate

Tuesday, January 6th, 2015

Some people say that osteoarthritis, cartilage degradation, and chronic joint pains degenerative diseases associated with agingare conditions with no cure, but Dr. Charlie Poblete and Dr. Jae Pak say otherwise.

It is a new era of medicine, opens Dr. Jae Pak, one of Koreas premier orthopedic stem cell surgeons and a visiting expert consultant of the Stem Care Orthopedics Department under Aivee Institute (AI). He was recently in the country to shed light on stem cell therapy and how it offers more accessible treament options for patients suffering from degenerative orthopedic conditions.

Dr. Pak was joined by Dr. Charlie Poblete, one of the countrys leading orthopedic surgeon who has a special interest on regenerative medicine and stem cells. Incidentally, Dr. Poblete is the head of the Stem Care Orthopedic Department of AI. Stem cells are not really part of alternative medicine. Its part of a modern medicine because we are talking about the biochemistry that goes on in the body with stem cell treatment, Dr. Charlie relates while adding, the good thing about medicine nowadays is its starting to look at the molecular aspect of the body, the molecular and cellular side of medicine.

Over the years, stem cell therapy has been touted as one procedure that can heal multitude of bone, cartilage, and joint ailments. Stem cells are the bodys natural healing cells. They are recruited by chemical signals emitted by damaged tissues to repair and regenerate the damaged cells. Stem cells derived from an individuals tissues may well be the next major development in medicine. In the right environment, these stem cells can change into bone, cartilage, muscle, fat, collagen, neural tissue, blood vessels, and even some organs. Stem cells may also effect healing by secreting special chemical messengers that repair damaged tissue.

There are many clinical conditions that benefits from stem cell therapy: heart attack patients have shown quicker healing period, improved condition for patients with multiple sclerosis, muscular dystrophy, Parkinsons disease, ALS, and stroke. Stem cells may also be effective in the treatment of macular degeneration, Crohns disease, and numerous pulmonary conditions. Also, stem cells are now used for patients with kidney failure and in the treatment of critical limb ischemia.

Stem Cell therapy is a simple procedure. Fat is aspirated from the tummy or the thighs, and then we separate the stem cells from them. It is then activated and injected into joints to restore and regenerate, explains Dr. Jae.

Stem Care by The Aivee Group is the countrys pioneer in advanced Autologous Stem Cell Therapy with an esteemed orthopedic team of doctors and surgeons regarded with international qualifications. The institute, with its CEO and medical director Dr. Z. Teo, together with his wife dermatologist Dr. Aivee Teo, now features a stronger multifaceted protocol in treating orthopedic ailments with a faster rate of positive patient response. They are also adept in complimentary therapies to further intensify the restorative powers of stem cells through the effective use of Growth Factors, Shockwave, Radio Frequency, and Electro Magnetic Therapies. 4033245, 4031982, 09209665613, 09175210222. http://www.stemcareinstitute.com

Continued here:
Restore and Regenerate

Read More...

Dallas, Tx – SVF Stem Cell Therapy Testimonial – Neuropathy – Video

Saturday, January 3rd, 2015


Dallas, Tx - SVF Stem Cell Therapy Testimonial - Neuropathy
http://www.innovationsstemcellcenter.com Call: 214.420.7970 Facebook: https://www.facebook.com/innovationsmedical Twitter: https://twitter.com/dallasdrj Instagram: http://instagram.com/drbilljo...

By: dallasdrj

Here is the original post:
Dallas, Tx - SVF Stem Cell Therapy Testimonial - Neuropathy - Video

Read More...

Page 5«..4567..1020..»


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick